APREA THERAPEUTICS INC (APRE) Stock Cash Flow
NASDAQ:APRE - Nasdaq - US03836J2015 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -14.08M | -12.96M | -14.29M | -112.66M | -37.13M | |||
| Depreciation Amortization | 21.50K | 22.30K | 7.10K | 0.00 | 10.00K | |||
| Change In Working Capital | 231.80K | -1.06M | 1.62M | -1.76M | -8.33M | |||
| Other non cash items | 575.80K | 435.10K | 483.40K | 89.41M | 7.76M | |||
| OPERATING CASH FLOW | -13.25M | -13.56M | -12.18M | -25.01M | -37.69M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -15.50K | -93.10K | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | N/A | -15.50K | -93.10K | 0.00 | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 200.00K | 16.14M | 5.79M | 680.00K | 1.75M | |||
| Other Financing Activity | -32.00K | -1.32M | -648.90K | N/A | N/A | |||
| FINANCING CASH FLOW | 168.10K | 14.82M | 5.14M | 680.00K | 1.75M | |||
| Exchange Rate Effect | -3.40K | -7.20K | -8.40K | 40.00K | 0.00 | |||
| CHANGE IN CASH | -13.09M | 1.24M | -7.14M | -24.29M | -35.94M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.25M | -13.56M | -12.18M | -25.01M | -37.69M | |||
| Capital Expenditure | N/A | -15.50K | -93.10K | 0.00 | 0.00 | |||
| FREE CASH FLOW | -13.26M | -13.57M | -12.27M | -25.01M | -37.69M | |||
All data in USD